Literature DB >> 31995005

Circular RNA and Diabetes: Epigenetic Regulator with Diagnostic Role.

Kazem Abbaszadeh-Goudarzi1, Shabnam Radbakhsh2, Mohammad Hossein Pourhanifeh3, Hashem Khanbabaei4, Amirhosein Davoodvandi5, Hadis Fathizadeh6, Amirhossein Sahebkar7, Mohammad Karim Shahrzad8, Hamed Mirzaei9.   

Abstract

Circular RNAs, a group of endogenous non-coding RNAs, are characterized by covalently closed cyclic structures with no poly-adenylated tails. It has been recently recommended that cirRNAs have an essential role in regulating genes expression by functioning as a translational regulator, RNA binding protein sponge and microRNA sponge. Due to their close relation to the progression of various diseases such as diabetes, circRNAs have become a research hotspot. A number of circRNAs (i.e., circRNA_0054633, circHIPK3, circANKRD36, and circRNA11783-2) have been shown to be associated with initiation and progression of diabetes. Based on reports, in a tissue, some circRNAs are expressed in a developmental stage-specific manner. In this study, we reviewed research on circular RNAs involved in the pathogenesis and diagnosis of diabetes and their prognostic roles. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Circular RNA; biomarker; circANKRD36; circHIPK3; circRNA_0054633; diabetes

Year:  2020        PMID: 31995005     DOI: 10.2174/1566524020666200129142106

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  16 in total

1.  Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7.

Authors:  Yisheng Gao; Jie Liu; Jing Huan; Fengyuan Che
Journal:  Cancer Cell Int       Date:  2020-07-22       Impact factor: 5.722

Review 2.  Disease-Associated Circular RNAs: From Biology to Computational Identification.

Authors:  Min Tang; Ling Kui; Guanyi Lu; Wenqiang Chen
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

3.  TCEB3 is Regulated by Circ-0000212/miR-140-3p Axis to Promote the Progression of Cervical Cancer.

Authors:  Yufeng Wang; Chuanhui Miao; Xiang Gao
Journal:  Onco Targets Ther       Date:  2021-04-28       Impact factor: 4.147

Review 4.  Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.

Authors:  Sally L Elshaer; Salma H Bahram; Pranav Rajashekar; Rajashekhar Gangaraju; Azza B El-Remessy
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

5.  Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage.

Authors:  Runjie Sun; Wei Liu; Yangang Zhao; Haoyu Chen; Zhenzhen Wang; Yanyu Zhang; Xiaoqi Sun; Xing Cui
Journal:  Cancer Cell Int       Date:  2021-06-13       Impact factor: 5.722

Review 6.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

Review 7.  Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19.

Authors:  Sisay Getu; Tegenaw Tiruneh; Henok Andualem; Wasihun Hailemichael; Teklehayimanot Kiros; Demeke Mesfin Belay; Mulugeta Kiros
Journal:  J Blood Med       Date:  2021-07-17

Review 8.  Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification.

Authors:  Duk-Hwa Kwon; Juhee Ryu; Young-Kook Kim; Hyun Kook
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

9.  Circular RNA MTO1 Inhibits the Proliferation and Invasion of Ovarian Cancer Cells Through the miR-182-5p/KLF15 Axis.

Authors:  Ning Wang; Qin-Xue Cao; Jun Tian; Lu Ren; Hai-Ling Cheng; Shao-Qin Yang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 10.  The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy.

Authors:  Zhixiao Fang; Chunjie Jiang; Shengli Li
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.